Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Protein Drug Discovery Company Launches, Gains $50M

A biotechnology enterprise founded by faculty at Scripps Research Institute plans to discover new therapies based on complex interactions with human proteins. . . . → Read More: Protein Drug Discovery Company Launches, Gains $50M

Simpler Lab Cell Production Techniques Devised

A process is being developed that makes it easier to produce healthy and diseased cells in the lab from human specimens for regenerative medicine and research. . . . → Read More: Simpler Lab Cell Production Techniques Devised

Scripps, Pfizer Collaborate on DNA-Coded Drug Discovery

Drug maker Pfizer Inc. is gaining access to advances in a synthetic chemistry technology developed by Scripps Research Institute that tags compounds with DNA identifiers. . . . → Read More: Scripps, Pfizer Collaborate on DNA-Coded Drug Discovery

Sanofi Licensing Antibody for Autoimmune Diseases

The global drug company Sanofi is licensing a synthetic antibody to treat autoimmune disorders being developed by a spin-off enterprise from Dartmouth College. . . . → Read More: Sanofi Licensing Antibody for Autoimmune Diseases

Ionis Options Cardiac Drugs in $1.5 Billion Deal

Biotechnology company Ionis Pharmaceuticals is providing drug maker Novartis first access to two experimental drugs for controlling proteins that promote cholesterol and triglycerides, which contribute to heart disease. . . . → Read More: Ionis Options Cardiac Drugs in $1.5 Billion Deal

Spin-Off Creates Enzyme to Prevent Celiac Disease

A spin-off enterprise from University of Washington is developing a synthetic enzyme that prevents dietary gluten from triggering symptoms of celiac disease. . . . → Read More: Spin-Off Creates Enzyme to Prevent Celiac Disease

Cell Biotech Gains Organoid Technology

A Canadian biotechnology enterprise is licensing a technology that generates organoids, three-dimensional clusters of cells from stem cells that can form into gastrointestinal organs. . . . → Read More: Cell Biotech Gains Organoid Technology

Patent Awarded for Whooping Cough Antibodies

An experimental treatment for pertussis, also known as whooping cough, using engineered humanized antibodies received a patent in the U.S. . . . → Read More: Patent Awarded for Whooping Cough Antibodies

Start-Up Developing Nanotech Bone Repairs

An enterprise formed earlier this year is licensing an engineered bone tissue repair technology that mixes ultrafine diamond particles with biocompatible polymers. . . . → Read More: Start-Up Developing Nanotech Bone Repairs

LEDs Shown to Reduce Alzheimer’s Brain Plaques

Pulsating LED lights were shown in lab mice to reduce amyloid-beta plaque deposits associated with Alzheimer’s disease on brain cells, with the lead researchers starting a company to commercialize the technology. . . . → Read More: LEDs Shown to Reduce Alzheimer’s Brain Plaques